Table 2 Two-Sample T-Tests for CDE Collection Ratios Between In-person and Virtual Visits
Phase 1 (week 1–12) | Phase 2 (week 13–32) | Phase 3 (week 33–68) | ||||
|---|---|---|---|---|---|---|
Mean (Standard deviation) | p-value | Mean (Standard deviation) | p-value | Mean (Standard deviation) | p-value | |
Arthritis Pain | ||||||
In-person Virtual | 0.73 (0.13) 0.38 (0.19) | < 0.001* | 0.86 (0.11) 0.60 (0.27) | 0.001* | 0.88 (0.07) 0.39 (0.42) | < 0.001* |
Patient Global Assessment | ||||||
In-person Virtual | 0.73 (0.12) 0.39 (0.18) | < 0.001* | 0.85 (0.11) 0.56 (0.28) | < 0.001* | 0.87 (0.08) 0.36 (0.41) | < 0.001* |
Active Joint Count | ||||||
In-person Virtual | 0.69 (0.16) 0.26 (0.16) | < 0.001* | 0.70 (0.12) 0.27 (0.24) | < 0.001* | 0.81 (0.16) 0.34 (0.39) | < 0.001* |
Provider Global Assessment | ||||||
In-person Virtual | 0.65 (0.15) 0.26 (0.19) | < 0.001* | 0.72 (0.14) 0.32 (0.23) | < 0.001* | 0.81 (0.14) 0.39 (0.40) | < 0.001* |